IL138824A0 - Process for manufacturing topical ophthalmic preparations without systemic effects - Google Patents

Process for manufacturing topical ophthalmic preparations without systemic effects

Info

Publication number
IL138824A0
IL138824A0 IL13882400A IL13882400A IL138824A0 IL 138824 A0 IL138824 A0 IL 138824A0 IL 13882400 A IL13882400 A IL 13882400A IL 13882400 A IL13882400 A IL 13882400A IL 138824 A0 IL138824 A0 IL 138824A0
Authority
IL
Israel
Prior art keywords
systemic effects
topical ophthalmic
ophthalmic preparations
manufacturing topical
manufacturing
Prior art date
Application number
IL13882400A
Original Assignee
Bakulesh Mafatlal Khamar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bakulesh Mafatlal Khamar filed Critical Bakulesh Mafatlal Khamar
Publication of IL138824A0 publication Critical patent/IL138824A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13882400A 1999-02-03 2000-02-02 Process for manufacturing topical ophthalmic preparations without systemic effects IL138824A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN90BO1999 IN185228B (en) 1999-02-03 1999-02-03
PCT/IN2000/000008 WO2000049990A2 (en) 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects

Publications (1)

Publication Number Publication Date
IL138824A0 true IL138824A0 (en) 2001-10-31

Family

ID=11077485

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13882400A IL138824A0 (en) 1999-02-03 2000-02-02 Process for manufacturing topical ophthalmic preparations without systemic effects

Country Status (11)

Country Link
EP (1) EP1139970A2 (en)
AP (1) AP2000001977A0 (en)
AU (1) AU4429100A (en)
BR (1) BR0004530A (en)
CA (1) CA2326690A1 (en)
EA (1) EA200000918A1 (en)
ID (1) ID28121A (en)
IL (1) IL138824A0 (en)
IN (1) IN185228B (en)
WO (1) WO2000049990A2 (en)
ZA (1) ZA200006252B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005220199B2 (en) * 2000-07-14 2007-03-08 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
NZ521185A (en) * 2000-07-14 2005-02-25 Allergan Inc Compositions containing alpha-2-adrenergic agonist components
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
DE10132876A1 (en) * 2001-07-06 2003-01-30 Medproject Pharma Entwicklungs Two-phase, drop-onable hydrogels for use on the eye
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
MXPA06013649A (en) 2004-05-25 2007-07-09 Sansrosa Pharmaceutical Dev In Compounds, formulations, and methods for treating or preventing inflammatory skin disorders.
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
FR2977493B1 (en) 2011-07-05 2014-02-14 Galderma Res & Dev NOVEL STABLE ANESTHETIC COMPOSITION FOR REDUCING SKIN REACTIONS
RU2641021C2 (en) 2013-02-15 2018-01-17 Аллерган, Инк. Implant for prolonged drug delivery
WO2014150899A1 (en) * 2013-03-15 2014-09-25 Chapin Matthew J Topical ophthalmic formulations for treating migraine
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
EP3302426A4 (en) 2015-05-29 2018-12-05 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
GB202110420D0 (en) * 2021-07-20 2021-09-01 Rosemont Pharmaceuticals Ltd Liquid pharmaceutical composition of clonidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (en) * 1977-11-07 1985-12-11 東興薬品工業株式会社 eye drops
DD294174A5 (en) * 1990-05-04 1991-09-26 Sigrid Keipert OPHTHALMIKA WITH RESET EFFECT AND A NEW PROCESS FOR THEIR MANUFACTURE
FR2678832B1 (en) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire NOVEL OPHTHALMIC COMPOSITIONS WITH IMPROVED RESORPTION AND METHODS OF PREPARING THE SAME.
FR2679773A1 (en) * 1991-07-30 1993-02-05 Merck Sharp & Dohme Ophthalmic preparation containing an acceptable antimicrobial osmotic agent
DE19614823A1 (en) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmic composition with prolonged retention time on the eye

Also Published As

Publication number Publication date
WO2000049990A3 (en) 2001-07-26
EA200000918A1 (en) 2001-10-22
IN185228B (en) 2000-12-09
WO2000049990A2 (en) 2000-08-31
CA2326690A1 (en) 2000-08-31
EP1139970A2 (en) 2001-10-10
BR0004530A (en) 2001-04-03
AU4429100A (en) 2000-09-14
ID28121A (en) 2001-05-03
AP2000001977A0 (en) 2000-12-31
ZA200006252B (en) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2001268690A1 (en) Manufacturing process for electrophoretic display
EP1156809A4 (en) Mucin containing ophthalmic preparations
IL131259A0 (en) Topical drug preparations
AU7859800A (en) Topical nasal treatment
AU2001255779A1 (en) Topical preparation for the treatment of hair loss
IL138824A0 (en) Process for manufacturing topical ophthalmic preparations without systemic effects
AU2001286221A1 (en) Remedies for ischemic diseases
AU4905499A (en) Topical aciclovir formulations
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU4904700A (en) Process for drying medicinal plants
AU2001263835A1 (en) Haemostatically active preparation containing vWF and method for the production thereof
GB9918760D0 (en) Topical treatment
AU1538901A (en) Polymersation process
AU4090299A (en) Liposomal delivery complex
AU6015400A (en) Glycyrrhizin preparations for transmucosal absorption
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
HUP0200483A2 (en) Liposome preparations
AU4396900A (en) Flouring process
AU2001255460A1 (en) Process for preparing lipid ii
AU4508101A (en) Lipid nanotubules for topical delivery
AU3624400A (en) Chromatographic albumin process
AU4417399A (en) Topical anti-fungal treatment for dandruff
AU1063001A (en) Process for encapsulating active agents in gels
AU4504201A (en) Drug preparations
AU2942100A (en) Vitamin d derivatives and process for the preparation thereof